Vinay M. Thomas

Oncology
1950 Circle Of Hope Dr
Salt Lake City, UT 84112

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 28 publications

Bone-Modifying Agents in Metastatic Castration-Resistant Prostate Cancer.

Bone-Modifying Agents in Metastatic Castration-Resistant Prostate Cancer.

Journal: JAMA network open
Published: June 24, 2026

Trends and Disparities in the Use of Next-Generation Sequencing in Patients With Cancer in the United States.

Trends and Disparities in the Use of Next-Generation Sequencing in Patients With Cancer in the United States.

Journal: JAMA network open
Published: April 07, 2026

Treatment patterns and outcomes with second-line therapies in patients with advanced urothelial carcinoma previously treated with first-line enfortumab vedotin with pembrolizumab.

Treatment patterns and outcomes with second-line therapies in patients with advanced urothelial carcinoma previously treated with first-line enfortumab vedotin with pembrolizumab.

Journal: Bladder cancer (Amsterdam, Netherlands)
Published: January 09, 2026

Receipt of PARP Inhibitors in Patients With Metastatic Prostate Cancer Harboring BRCA1/2 Alterations.

Receipt of PARP Inhibitors in Patients With Metastatic Prostate Cancer Harboring BRCA1/2 Alterations.

Journal: JAMA network open
Published: October 02, 2025

Treatment and Attrition Trends for Metastatic Clear Cell Renal Cell Carcinoma in the US.

Treatment and Attrition Trends for Metastatic Clear Cell Renal Cell Carcinoma in the US.

Journal: JAMA network open
Published: March 20, 2025

Trends and Disparities in Next-Generation Sequencing in Metastatic Prostate and Urothelial Cancers.

Trends and Disparities in Next-Generation Sequencing in Metastatic Prostate and Urothelial Cancers.

Journal: JAMA network open
Published: July 18, 2024

Differential Tumor Gene Expression Profiling of Patients With Prostate Adenocarcinoma on the Basis of BMI.

Differential Tumor Gene Expression Profiling of Patients With Prostate Adenocarcinoma on the Basis of BMI.

Journal: JCO precision oncology
Published: May 23, 2024

Treatment Patterns and Attrition With Lines of Therapy for Advanced Urothelial Carcinoma in the US.

Treatment Patterns and Attrition With Lines of Therapy for Advanced Urothelial Carcinoma in the US.

Journal: JAMA network open
Published: May 02, 2024

Treatment Patterns and Outcomes by Age in Metastatic Urinary Tract Cancer: A Retrospective Tertiary Cancer Center Analysis.

Treatment Patterns and Outcomes by Age in Metastatic Urinary Tract Cancer: A Retrospective Tertiary Cancer Center Analysis.

Journal: Cancers
Published: April 07, 2024

Differences in Tumor Gene Expression Profiles Between De Novo Metastatic Castration-sensitive Prostate Cancer and Metastatic Relapse After Prior Localized Therapy.

Differences in Tumor Gene Expression Profiles Between De Novo Metastatic Castration-sensitive Prostate Cancer and Metastatic Relapse After Prior Localized Therapy.

Journal: European urology oncology
Published: December 29, 2023

Natural course of metastatic castration-resistant prostate cancer in the era of intensified androgen deprivation therapy in the hormone-sensitive setting.

Natural course of metastatic castration-resistant prostate cancer in the era of intensified androgen deprivation therapy in the hormone-sensitive setting.

Journal: The Prostate
Published: December 07, 2023

Cabozantinib with immune checkpoint inhibitor versus cabozantinib monotherapy in patients with metastatic clear cell renal cell carcinoma progressing after prior immune checkpoint inhibitor.

Cabozantinib with immune checkpoint inhibitor versus cabozantinib monotherapy in patients with metastatic clear cell renal cell carcinoma progressing after prior immune checkpoint inhibitor.

Journal: Cancer
Published: December 04, 2023
Showing 1-12 of 28

Last Updated: 09/26/2026